Multiplex Assay Kit for Hepatocyte Growth Factor (HGF) ,etc. by FLIA (Flow Luminescence Immunoassay)

HGF; F-TCF; HGFB; HPTA; SF; Scatter Factor; Hepapoietin A; Fibroblast-Derived Tumor Cytotoxic Factor; Lung Fibroblast-Derived Mitogen

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Hepatocyte Growth Factor (HGF) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Hepatocyte Growth Factor (HGF) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Hepatocyte Growth Factor (HGF) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Hepatocyte Growth Factor (HGF) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-96 91
EDTA plasma(n=5) 83-102 90
heparin plasma(n=5) 87-101 97
sodium citrate plasma(n=5) 88-96 93

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Hepatocyte Growth Factor (HGF) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Hepatocyte Growth Factor (HGF) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Hepatocyte Growth Factor (HGF) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 97-105% 83-101% 97-104% 80-104%
EDTA plasma(n=5) 95-102% 89-96% 94-105% 89-98%
heparin plasma(n=5) 96-105% 78-96% 89-105% 98-105%
sodium citrate plasma(n=5) 79-101% 82-91% 90-98% 89-96%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:HGF) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Gene Therapy and Molecular Biology Sphingosine kinase-1 protects transplanted mesenchymal stem cells and improves the performance of the infarcted heart LWW: 01000
Journal of Translational Medicine Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma BioMed: 14795876
Digestive Diseases and Sciences Gene Transfer of c-met Confers Protection Against d-Galactosamine/Lipopolysaccharide-Induced Acute Liver Failure SpringerLink: k22823l138x2344x
Biomarker insights Correlation Between Hepatocyte Growth Factor (HGF) and Gamma-Aminobutyric Acid (GABA) Plasma Levels in Autistic Children PubMed: PMC3694825
Biomarker insights Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD) PubMed: PMC3762604
BMC cell biology BMSCs reduce rat granulosa cell apoptosis induced by cisplatin and perimenopause PubMed: PMC3640998
Cell Journal (Yakhteh) Effect of Mesenchymal Stem Cells on Doxorubicin-Induced Fibrosis PubMed: PMC3584430
Gastroenterol Res Pract Proinflammatory Cytokines (IL-1α, IL-6) and Hepatocyte Growth Factor in Patients with Alcoholic Liver Cirrhosis PubMed: 26448742
Tumor Biology Hypoxia-induced secretion of IL-11 from adipose-derived mesenchymal stem cell promotes growth and cancer stem cell properties of Burkitt lymphoma PubMed: 26695151
Cytotherapy Cell type–dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury PubMed: 25863963
Biomedicine & Pharmacotherapy Silymarin-loaded Eudragit® RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats Pubmed:27261582
Can J Physiol Pharmacol.  Piceatannol increases the expression of hepatocyte growth factor and IL-10 thereby protecting hepatocytes in thioacetamide-induced liver fibrosis Pubmed:27186801
Genet Mol Res Changes in growth factor levels in the cerebrospinal fluid of autism patients after transplantation of human umbilical cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells Pubmed:27323064
Changes in HGF levels after a progressive test before and after Tabata HIIT program profile:Pawel_Wolanski3
Stem Cell Research & Therapy Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats 10.1186/s13287-017-0739-3
Oncology Letters Carcinoma associated fibroblasts derived from oral squamous cell carcinoma promote lymphangiogenesis via c‑Met/PI3K/AKT in vitro 10.3892/ol.2017.7301
Stem Cell Research & Therapy Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure. pubmed:28679425
Nature Communications Pulmonary pericytes regulate lung morphogenesis Pubmed:29934496
Experimental And Molecular Medicine Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke … Pubmed:29650950
Oncology Letters Carcinoma associated fibroblasts derived from oral squamous cell carcinoma promote lymphangiogenesis via c-Met/PI3K/AKT in vitro Pubmed:29375714
Bulletin of Experimental Biology and Medicine Dynamics of Expression of Cytokine Genes and Macrophage Content in the Lungs and Kidneys after Subtotal Hepatectomy in Rats Pubmed:29796817
Cell Biology International Inherent control of hepatocyte proliferationInherent control of hepatocyte proliferation after subtotal liver resection Pubmed: 31297922
Journal of stem cells & regenerative medicine What is the Best Degree of Hyaluronic Acid Crosslinking in Increasing Growth Factors Level of Platelet-Rich Fibrin Lysate? Pubmed: 31239605
Open Journal of Veterinary Medicine Efficacy of autologous bone marrow mononuclear cell transplantation in dogs with chronic spinal cord injury Pubmed: 32821665
Stem Cell Reviews and Reports Prospects on the Potential In Vitro Regenerative Features of Mechanically Treated-Adipose Tissue for Osteoarthritis Care 33469783
Molecular Biology Reports Umbilical cord-derived mesenchymal stem cell conditioned medium reverses neuronal oxidative injury by inhibition of TRPM2 activation and the JNK signaling … Pubmed:35585377
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APA047Hu02 Active Hepatocyte Growth Factor (HGF) Cell culture; Activity Assays.
RPA047Hu03 Recombinant Hepatocyte Growth Factor (HGF) Positive Control; Immunogen; SDS-PAGE; WB.
APA047Hu01 Active Hepatocyte Growth Factor (HGF) Cell culture; Activity Assays.
RPA047Hu01 Recombinant Hepatocyte Growth Factor (HGF) Positive Control; Immunogen; SDS-PAGE; WB.
RPA047Hu02 Recombinant Hepatocyte Growth Factor (HGF) Positive Control; Immunogen; SDS-PAGE; WB.
PAA047Hu01 Polyclonal Antibody to Hepatocyte Growth Factor (HGF) WB; IHC; ICC; IP.
PAA047Hu02 Polyclonal Antibody to Hepatocyte Growth Factor (HGF) WB; IHC; ICC; IP.
PAA047Hu03 Polyclonal Antibody to Hepatocyte Growth Factor (HGF) WB; IHC; ICC; IP.
LAA047Hu71 Biotin-Linked Polyclonal Antibody to Hepatocyte Growth Factor (HGF) WB; IHC; ICC.
LAA047Hu53 APC-Linked Polyclonal Antibody to Hepatocyte Growth Factor (HGF) WB; IHC; ICC; IF.
LAA047Hu81 FITC-Linked Polyclonal Antibody to Hepatocyte Growth Factor (HGF) WB; IHC; ICC; IF.
MAA047Hu22 Monoclonal Antibody to Hepatocyte Growth Factor (HGF) WB,IHC
RAA047Hu21 Recombinant Antibody to Hepatocyte Growth Factor (HGF) WB; IF; ICC; IHC; IP; FCM.
MAA047Hu23 Monoclonal Antibody to Hepatocyte Growth Factor (HGF) WB; IHC; ICC; IP.
SEA047Hu ELISA Kit for Hepatocyte Growth Factor (HGF) Enzyme-linked immunosorbent assay for Antigen Detection.
MEA047Hu Mini Samples ELISA Kit for Hepatocyte Growth Factor (HGF) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA047Hu CLIA Kit for Hepatocyte Growth Factor (HGF) Chemiluminescent immunoassay for Antigen Detection.
LMA047Hu Multiplex Assay Kit for Hepatocyte Growth Factor (HGF) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA047Hu01 ELISA Kit DIY Materials for Hepatocyte Growth Factor (HGF) Main materials for "Do It (ELISA Kit) Yourself".